Journal article
Adjunctive Hyperbaric Oxygen Therapy (HBOT) in Patients with Primary Immunodeficiency
Journal of allergy and clinical immunology, v 135(2), pp AB183-AB183
01 Feb 2015
Abstract
Additionally, this adjunctive therapy was safe, with no adverse effects. Because of the delayed healing and the complications that accompany soft tissue infections in the immune compromised host, adjunctive treatments such as HBOT should be considered.
Metrics
10 Record Views
Details
- Title
- Adjunctive Hyperbaric Oxygen Therapy (HBOT) in Patients with Primary Immunodeficiency
- Creators
- Lorena Pereira - Duke Medical CenterDaniel Conway - St. Christopher's Hospital for Children
- Publication Details
- Journal of allergy and clinical immunology, v 135(2), pp AB183-AB183
- Publisher
- Elsevier Limited
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000361129600591
- Other Identifier
- 991021463574704721
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Allergy
- Immunology